Miromatrix Medical Alpha and Beta Analysis
| MIRODelisted Stock | USD 1.49 0.22 12.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Miromatrix Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Miromatrix Medical over a specified time horizon. Remember, high Miromatrix Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Miromatrix Medical's market risk premium analysis include:
Beta (0.59) | Alpha 0.49 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Miromatrix |
Miromatrix Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Miromatrix Medical market risk premium is the additional return an investor will receive from holding Miromatrix Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Miromatrix Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Miromatrix Medical's performance over market.| α | 0.49 | β | -0.59 |
Miromatrix Medical Fundamentals Vs Peers
Comparing Miromatrix Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Miromatrix Medical's direct or indirect competition across all of the common fundamentals between Miromatrix Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Miromatrix Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Miromatrix Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Miromatrix Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Miromatrix Medical to competition |
| Fundamentals | Miromatrix Medical | Peer Average |
| Return On Equity | -1.14 | -0.31 |
| Return On Asset | -0.56 | -0.14 |
| Operating Margin | (593.69) % | (5.51) % |
| Current Valuation | 80.11 M | 16.62 B |
| Shares Outstanding | 27.42 M | 571.82 M |
| Shares Owned By Insiders | 23.95 % | 10.09 % |
| Shares Owned By Institutions | 25.75 % | 39.21 % |
Miromatrix Medical Opportunities
Miromatrix Medical Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Miromatrix Medical Inc. Q1 2023 Earnings Call Transcript | 05/17/2023 |
2 | UPDATE 5-JJ expects cancer drugs, medical devices to drive growth in 2023 - Yahoo Finance | 07/20/2023 |
About Miromatrix Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Miromatrix or other delisted stocks. Alpha measures the amount that position in Miromatrix Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Miromatrix Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Miromatrix Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Miromatrix Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Miromatrix Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Miromatrix Medical. Please utilize our Beneish M Score to check the likelihood of Miromatrix Medical's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Miromatrix Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world |